Recommendations of Active Surveillance for Intermediate-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recommendations of Active Surveillance for Intermediate-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists

Published:2019-03 Issue:2 Volume:2 Page:189-195
ISSN:2588-9311
Container-title:European Urology Oncology
language:en
Short-container-title:European Urology Oncology

Author:

Kim Simon P.,Shah Nilay D.,Meropol Neal J.,Tilburt Jon C.,Nguyen Paul L.,Yu James B.,Abouassaly Robert,Kim Albert,Gross Cary P.

Publisher

Elsevier BV

Subject

Urology,Radiology Nuclear Medicine and imaging,Oncology,Surgery

Reference29 articles.

1. Cancer statistics, 2017;Siegel;CA Cancer J Clin,2017

2. Prostate cancer incidence and PSA testing patterns in relation to USPSTF screening recommendations;Jemal;JAMA,2015

3. Increase in prostate cancer distant metastases at diagnosis in the United States;Hu;JAMA Oncol,2017

4. The effect of the USPSTF PSA screening recommendation on prostate cancer incidence patterns in the USA;Fleshner;Nat Rev Urol,2017

5. Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005;Welch;J Natl Cancer Inst,2009

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Using active surveillance for Gleason 7 (3+4) prostate cancer: A narrative review;Canadian Urological Association Journal;2023-12-21

2. Patterns of multispecialty care for low- and intermediate-risk prostate cancer in the use of active surveillance;Urologic Oncology: Seminars and Original Investigations;2023-09

3. Increasing trend of utilising active surveillance for Gleason Score 7 (3 + 4) prostate cancer;BJU International;2023-08-31

4. Validation of the prognostic value of a three‐gene signature and clinical parameters‐based risk score in prostate cancer patients;The Prostate;2023-06-08

5. Editorial Comment to “A national questionnaire survey of Japanese urologists on active surveillance for low‐ and intermediate‐risk prostate cancer”;International Journal of Urology;2022-12-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3